Cargando…
Use of Anti-Interleukin-6 Receptor Monoclonal Antibody in Drug-Induced Acute Respiratory Distress Syndrome
Acute respiratory distress syndrome (ARDS) is a disorder that involves the activation of alveolar macrophages triggering the innate immune system. The parenchymal lung injury seen in ARDS is a result of many proinflammatory elevations including interleukin-6. There remains no effective standard of c...
Autores principales: | Petrillo, Alessandra, Biran, Noa, Sadikot, Sean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396067/ https://www.ncbi.nlm.nih.gov/pubmed/32774934 http://dx.doi.org/10.1155/2020/8832986 |
Ejemplares similares
-
Anti-interleukin-6 monoclonal antibody for cytokine storm in COVID-19
por: Douedi, Steven, et al.
Publicado: (2020) -
Changes in Iron Metabolism Induced by Anti-Interleukin-6 Receptor Monoclonal Antibody are Associated with an Increased Risk of Infection
por: Ribeiro, Renata, et al.
Publicado: (2019) -
SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody
por: Jugler, Collin, et al.
Publicado: (2021) -
Monoclonal antibodies reactive with the mouse interleukin 5 receptor
Publicado: (1989) -
Mouse Anti‐human Interleukin‐6 Receptor Monoclonal Antibody Inhibits Proliferation of Fresh Human Myeloma Cells in vitro
por: Goto, Hideo, et al.
Publicado: (1994)